Lunaphore Technologies S.A.. (4/21/20). "Press Release: Lunaphore Receives Additional CHF 2M in Series C2 Financing, Bringing Total Series C Round to CHF 25M". Lausanne.

	Organisation	Lunaphore Technologies S.A.
	Group	Bio-Techne (Group)
	Organisation 2	Credit Suisse (Group)
	Today	UBS (Group)
	Group	UBS (Group)
	Product	FFeX technology (Fast Fluidic Exchange technology)
	Product 2	venture capital
	Index term	Lunaphore–Swiss Entrepreneurs Foundation: investment, 202004 additional CHF2m Series C2 financing from Swiss Entrerpreneurs Fund
	Index term 2	Lunaphore–SEVERAL: investment, 202001 financing round Series C CHF23m led by PHC Holdings Corp
	Person	Denat, Didier (Swiss Entrepreneurs Fund 202004 + Credit Suisse (Switzerland) Ltd 202004)
	Person 2	Büchler, Andrea (Lunaphore 201808 Finance + Business Development)

Lunaphore Technologies SA, a Swiss life-sciences company developing innovative next-generation equipment for cancer research and tissue diagnostics, announces the second closing of its Series C round totaling CHF 25M.

The CHF 2M Series C2 financing was provided by the Swiss Entrepreneurs Fund, who invested a total of CHF 5M in the company. The fund is linked to the Swiss Entrepreneurs Foundation, whose main focus is to invest in Swiss start-ups and SMEs in the growth phase (internationalization) with the goal of bridging the financing gap in Swiss innovation.

Didier Denat, Member of the Decision Committee for direct investments of the Swiss Entrepreneurs Fund and Head of Corporate Banking at Credit Suisse (Switzerland) Ltd. said: “With its outstanding management team and technological USPs, Lunaphore is able to show significant market traction, combined with a high degree of customer satisfaction. We are fully convinced in both the business model and strategy of Lunaphore and we are happy to contribute in taking the company to the next level.”

The proceeds of the overall CHF 25M Series C closing, with the first closing announced on February 6, 2020 and led by the Japanese strategic investor PHC Holdings Corporation (PHCHD), will be dedicated to market and product expansion, including a US market entry, the ramp up of activities in Europe and the development of next generation of instruments.

“We are very happy to add the Swiss Entrepreneurs Fund, which focuses on high-growth companies with global ambitions, to our investors’ base. Together with the strategic investment from PHCHD that we recently closed, Lunaphore is now backed by very strong institutions to achieve its vision.”

About Lunaphore

Lunaphore Technologies S.A. is a Swiss company developing next generation tissue autostainers. The award-winning technology based on microfluidics is called FFeX (Fast Fluidic Exchange). It aims to perform assays much faster than standard techniques and has demonstrated good results in tests with cancer patient samples. Lunaphore was founded in 2014 with the vision of bringing –omics like approaches to tissue analytics and has been recognized as one of the most innovative companies nationally and internationally. For further information on Lunaphore and its products, please visit www.lunaphore.com.

About Swiss Entrepreneurs Fund

Launched jointly by the Swiss Entrepreneurs Foundation, Swiss Mobiliar, Credit Suisse and UBS, the Swiss Entrepreneurs Fund invests in Swiss start-ups and growth-stage innovative SMEs that already have products on the market and an established client base. The fund has a unique connection to the Swiss Entrepreneurs Foundation, which was launched by Swiss Mobiliar, Credit Suisse, UBS, Swisscom, the Gebert Rüf Foundation and Wenger & Vieli. The fund invests directly and through third-party funds in companies that have their headquarters or a significant share of their value added in Switzerland. Credit Suisse is responsible for the direct investments, while UBS is in charge for selecting the fund investments.

For further information contact:

LUNAPHORE

Irene Tamayo
Lunaphore Corporate Communications
Email: [email protected]
Phone: +41 21 353 58 22

Andrea Büchler
Lunaphore Finance and Business Development
Email: [email protected]
Phone +41 79 598 40 73

Record changed: 2023-06-05